Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Trial Investigating the Effect of Subcutaneous Semaglutide on Liver Fibrosis Assessed by Magnetic Resonance Elastography in Subjects With Non-alcoholic Fatty Liver Disease

Next Previous
X
Search
Trial Profile

A Trial Investigating the Effect of Subcutaneous Semaglutide on Liver Fibrosis Assessed by Magnetic Resonance Elastography in Subjects With Non-alcoholic Fatty Liver Disease

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 08 Aug 2023

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Semaglutide (Primary)
  • Indications Hepatic fibrosis; Non-alcoholic fatty liver disease
  • Focus Therapeutic Use
  • Sponsors Novo Nordisk

    • Most Recent Events

    • 24 Jun 2023 Data from 3 studies were taken from NCT03357380, NCT02970942 & NCT03987451 assessing the impact of T2D and other cardiometabolic parameters on weight loss presented at the European Association for the Study of the Liver Congress 2023.
    • 27 Sep 2021 Primary endpoint (Change in liver stiffness (kPa) assessed by magnetic resonance elastography (MRE) has not been met according to the results published in the Alimentary Pharmacology and Therapeutics
    • 27 Sep 2021 Results published in the Alimentary Pharmacology and Therapeutics

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top